Vaccine Therapy in Treating Patients With Stage IV Melanoma
Completed · Phase 1
Conditions studied: Melanoma (Skin)
In brief
Randomized phase I trial to study the effectiveness of vaccine therapy in treating patients who have stage IV melanoma. Vaccines may make the body build an immune response to kill tumor cells.
Key facts
- Study ID
- NCT00003665
- Run by
- National Cancer Institute (NCI)
- People needed
- 40
- Starts
- 1999-04-01
- Expected to finish
- 2002-11-01
- Last updated by the study team
- 2013-02-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Pennsylvania Cancer Center — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.